Cancer Cell differentiation insight could help develop rhabdomyosarcoma treatment Sep. 5, 2023 By Helen Albert Investigators at Cold Spring Harbor Laboratory have discovered a method of switching cancerous rhabdomyosarcoma cells back into normal muscle cells that could lead to the development of a treatment for this rare aggressive childhood cancer.Read More
KDM4B enzyme inhibitor tested for aggressive rhabdomyosarcoma July 14, 2022 By Mar de Miguel An effective treatment could be found for one of the most aggressive pediatric cancers, alveolar rhabdomyosarcoma (aRMS).Read More